Has Iriagbonse Asemota received payments from drug or device companies?

Yes. Drug and device makers reported $43,094 in general payments to Iriagbonse Asemota across 381 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Iriagbonse Asemota did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Iriagbonse Asemota come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Iriagbonse Asemota

Internal Medicine · Chicago, ILNPI 1629621461

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $29,559 of the $43,094 with a category attached, or 68.6%. 23 manufacturers reported payments, led by Biotronik Inc. at 28.8% of the total. 2025 is the largest year on record at $33,852, more than ten times the $256 reported in 2022. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,094in general payments, 2019–2025

Across 381 payments — averaging $113.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biotronik Inc.$12K
Abbott$9K
Medtronic$8K
Biosense Webster, Inc.$6K
Boston Scientific$3K
Medical Device Business Services, Inc.$2K
plus $3K from 17 others

What the payments were for

Travel & lodging$29,55969%
Food & beverage$13,11430%
Education$4211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biotronik Inc.	43	$12,397
Abbott	75	$9,002
Medtronic	93	$8,326
Biosense Webster, Inc.	58	$5,996
Boston Scientific	17	$3,014
Medical Device Business Services, Inc.	12	$1,720
Amgen	25	$407
Abiomed	8	$358
Philips North America LLC	3	$321
Johnson & Johnson(2 entities)	4	$216
Pfizer	10	$208
Boehringer Ingelheim	9	$192
Edwards Lifesciences	1	$159
Terumo Medical Corporation	1	$151
Novartis	6	$139
W. L. Gore & Associates, Inc.	2	$123
Actelion Pharmaceuticals US, Inc.	4	$112
Cardiva Medical, Inc.	2	$67
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$58
Kiniksa Pharmaceuticals International, PLC	2	$42
AstraZeneca	2	$37
Bridgebio Pharma, Inc.	1	$31
Bayer	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,094 in reported general payments places this provider in the 95th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois →

Other internal medicine in Chicago

Merle DiamondChicago$1.1M
Robert KushnerChicago$516K
Romeo UrsuaChicago$420K
Peter O DonnellChicago$318K
George UrbanChicago$258K
Kristen PallokChicago$256K
George NissanChicago$252K
Luke LaffinChicago$162K
Daniel CatenacciChicago$161K
Hiren ShahChicago$144K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →